nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis
|
Won, Il |
|
|
20 |
3 |
p. e253-e262 |
artikel |
2 |
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?
|
Roy, Amit |
|
|
20 |
3 |
p. e227-e232 |
artikel |
3 |
Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database
|
Celtik, Kenan |
|
|
20 |
3 |
p. 244-251 |
artikel |
4 |
Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population
|
Zhu, Denzel |
|
|
20 |
3 |
p. 299-299.e10 |
artikel |
5 |
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
|
Anand, Aseem |
|
|
20 |
3 |
p. 270-277 |
artikel |
6 |
Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma
|
Yin, Jianyi |
|
|
20 |
3 |
p. 260-269 |
artikel |
7 |
Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients
|
Jeyapala, Renu |
|
|
20 |
3 |
p. e217-e226 |
artikel |
8 |
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets
|
Kappel, Coralea |
|
|
20 |
3 |
p. 278-284 |
artikel |
9 |
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer
|
Chatzkel, Jonathan |
|
|
20 |
3 |
p. 252-259 |
artikel |
10 |
Editorial Board
|
|
|
|
20 |
3 |
p. A1 |
artikel |
11 |
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma
|
Patel, Hiren V. |
|
|
20 |
3 |
p. 296-296.e9 |
artikel |
12 |
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer
|
Ramamurthy, Chethan |
|
|
20 |
3 |
p. 237-243 |
artikel |
13 |
Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups
|
Sirohi, Deepika |
|
|
20 |
3 |
p. e233-e243 |
artikel |
14 |
Identification of Different miRNAs and Their Relevant miRNA Targeted Genes Involved in Sister Chromatid Cohesion and Segregation (SCCS)/chromatin Remodeling Pathway on T1G3 Urothelial Carcinoma (UC) Response to BCG Immunotherapy
|
Awadalla, Amira |
|
|
20 |
3 |
p. e181-e189 |
artikel |
15 |
Impact of 18 FDG- PET CT in the Management of Muscle Invasive Bladder Cancer
|
Bertolaso, Pauline |
|
|
20 |
3 |
p. 297-297.e6 |
artikel |
16 |
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer
|
Saout, Kevin |
|
|
20 |
3 |
p. e244-e252 |
artikel |
17 |
Modified 5-Item Frailty Index Score as Prognostic Marker After Radical Cystectomy in Bladder Cancer
|
Yamashita, Shimpei |
|
|
20 |
3 |
p. e210-e216 |
artikel |
18 |
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study
|
Grossmann, Nico C. |
|
|
20 |
3 |
p. 227-236 |
artikel |
19 |
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
|
Santoni, Matteo |
|
|
20 |
3 |
p. 285-295 |
artikel |
20 |
Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT
|
Hutten, Ryan |
|
|
20 |
3 |
p. e263-e269 |
artikel |
21 |
Parenchymal Mass Loss During Partial Nephrectomy: Role of Devascularized Parenchymal Mass and Excised Parenchymal Mass and Impact on Functional Preservation
|
Liu, Qi |
|
|
20 |
3 |
p. e199-e204 |
artikel |
22 |
Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies
|
Strausser, Sarah A. |
|
|
20 |
3 |
p. 298-298.e11 |
artikel |
23 |
RNA sequencing in a penile cancer cohort: an investigation of biomarkers of cisplatin resistance and potential therapeutic drug targets
|
Ibilibor, Christine |
|
|
20 |
3 |
p. 219-226 |
artikel |
24 |
Single Positive Core Prostate Cancer at Biopsy: Clinicopathological Implications and Risk Factors for Adverse Pathological Outcomes
|
Mao, Qiqi |
|
|
20 |
3 |
p. e205-e209 |
artikel |
25 |
Table of contents
|
|
|
|
20 |
3 |
p. A3-A7 |
artikel |
26 |
The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance
|
Colomer Gallardo, Anna |
|
|
20 |
3 |
p. 199-209 |
artikel |
27 |
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy
|
Martini, Alberto |
|
|
20 |
3 |
p. e190-e198 |
artikel |
28 |
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
|
Thana, Myuran |
|
|
20 |
3 |
p. 210-218 |
artikel |